Proteomic Insights: Down Syndrome vs. Alzheimer’s CSF
In a groundbreaking study set to redefine our understanding of neurodegenerative diseases, researchers have performed an unprecedented proteomic analysis of cerebrospinal fluid (CSF) from individuals with Down syndrome (DS). This investigation critically compares the molecular landscape of DS-associated neuropathology with that found in late-onset Alzheimer’s disease (LOAD) and autosomal dominant Alzheimer’s disease (ADAD), yielding insights […]
In a groundbreaking study set to redefine our understanding of neurodegenerative diseases, researchers have performed an unprecedented proteomic analysis of cerebrospinal fluid (CSF) from individuals with Down syndrome (DS). This investigation critically compares the molecular landscape of DS-associated neuropathology with that found in late-onset Alzheimer’s disease (LOAD) and autosomal dominant Alzheimer’s disease (ADAD), yielding insights […]
What's Your Reaction?
